BIOSCIENCE SECURITIES
BioScience Securities offers corporate advisory and investment banking services to technology, agriculture, and health care sectors.
BIOSCIENCE SECURITIES
Industry:
Consulting Financial Services Health Care
Founded:
1994-01-01
Address:
Venice, California, United States
Country:
United States
Website Url:
http://www.bioscience-securities.com
Total Employee:
1+
Status:
Active
Contact:
+1 310.452.8783
Email Addresses:
[email protected]
Technology used in webpage:
Amazon Hostway DNS
Similar Organizations
Petsky Prunier LLC
Leading investment bank to the technology, media, marketing, eCommerce, and healthcare industries.
Rohrscheib Capital
Rohrscheib Capital is an investment management and venture capital firm that invests in the agricultural and healthcare sectors.
Square Peg Ventures
Investment group coordinating direct and syndicated investments in early-stage technology companies and income producing real estate assets.
Current Employees Featured
Founder
Official Site Inspections
http://www.bioscience-securities.com
- Host name: ec2-52-2-192-9.compute-1.amazonaws.com
- IP address: 52.2.192.9
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "BioScience Securities"
BIOSCIENCE SECURITIES, INC. - Financial Industry Regulatory …
BIOSCIENCE SECURITIES, INC. Section Title Report Summary Registration and Withdrawal Firm History CRD# 35477 1 2 6 Firm Profile 3 - 5 Page(s) ... Organization Affiliates This …See details»
BioScience Securities Company Profile | Management and
BioScience Securities Profile and History. BioScience Securities is a strategic corporate advisory and investment-banking firm founded in 1994 in Orinda, California (San Francisco Bay area) to …See details»
BioScience Securities - Contacts, Employees, Board Members
Organization. BioScience Securities . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 1. About. BioScience …See details»
BioScience Securities - Overview, News & Competitors - ZoomInfo
BioScience Securities. Business Services · California, United States · <25 Employees. BioScience Securities is a strategic corporate advisory and investment-banking firm founded in …See details»
BioScience Securities - Crunchbase
BioScience Securities offers corporate advisory and investment banking services to technology, agriculture, and health care sectors.See details»
Aadi Bioscience Transforms with In-Licensing of Novel ADC …
4 days ago LOS ANGELES, Dec. 19, 2024 /PRNewswire/ -- Aadi Bioscience, Inc. (NASDAQ: AADI) today announced it has entered into an exclusive license agreement for development …See details»
Aadi Bioscience signs license agreement for ADC portfolio
3 days ago Aadi Bioscience (AADI) has entered into an exclusive license agreement for development and global commercialization of a three-asset portfolio of preclinical, next-wave …See details»
Aadi Bioscience selling Fyarro and infrastructure for $100M
3 days ago Aadi Bioscience (AADI) announced that Kaken Pharmaceutical, an R&D driven pharmaceutical company in Japan, has entered into a stock purchase agreement under which …See details»
Aadi Bioscience Transforms with In-Licensing of Novel …
3 days ago Aadi Bioscience Transforms with In-Licensing of Novel ADC Portfolio, $100 Million Sale of FYARRO® and $100 Million PIPE Financing ... a leading global Contract Research, Development and Manufacturing …See details»
Bloom Burton & Co. Inc. Announces Changes to Holdings in …
2 days ago Toronto, Ontario--(Newsfile Corp. - December 20, 2024) - Bloom Burton & Co. Inc. (Bloom Burton) announces that, today, it acquired 1,692,250 common shares (Shares) of …See details»
Satellos Bioscience closes $56.96 million public offering led by …
Satellos Bioscience Inc. announced on December 17, 2024, and closed on December 20, 2024, a $56,956,500 CAD public offering. The deal included 63,285,000 common shares priced at …See details»
BioScience Securities - Tech Stack, Apps, Patents & Trademarks
BioScience Securities offers corporate advisory and investment banking services to technology, agriculture, and health care sectors.See details»
Aadi Bioscience Secures $200M in Strategic Deals, Expands …
3 days ago Aadi Bioscience (NASDAQ: AADI) has announced three major strategic moves: an exclusive license agreement for three preclinical antibody-drug conjugates (ADCs), a $100 …See details»
Ontario Securities Commission Company Overview, Contact …
Sep 24, 2024 Ontario Securities Commission partners with Ontario Bioscience Innovation Organization. In partnership with Blakes and the Ontario Bioscience Innovation Organization, …See details»
Aadi Bioscience Transforms with In-Licensing of Novel ADC
4 days ago Aadi Bioscience Transforms with In-Licensing of Novel ADC Portfolio, $100 Million Sale of FYARRO® and $100 Million PIPE Financing PR Newswire LOS ANGELES, Dec. 19, …See details»
Dare Bioscience Inc. | Desjardins Securities - (DSIA) | Desjardins ...
Nov 20, 2024 Desjardins Securities Inc. uses the trade name Desjardins Online Brokerage for its discount brokerage activities. Discount brokerage products and services are consolidated …See details»
Aadi Biosciences: Entry Into A Material Definitive Agreement ...
Jun 11, 2024 Item 1.01 Entry into a Material Definitive Agreement. Stock Purchase Agreement On December 19, 2024, Aadi Bioscience, Inc. (“Aadi”) entered into a Stock Purchase …See details»
Vator | Vator Securities
Dec 13, 2024 Vator Securities advises Alligator Bioscience on 280 MSEK Capital Raise. 2024-12-13. ... Vator Securities serves as a strategic partner for both companies seeking capital to …See details»
Lexaria Bioscience : Material Definitive Agreement Form 8 K
4 days ago Item 1.0 Entry into a Material Definitive Agreement. Lexaria Bioscience Corp. via its wholly owned subsidiary, Lexaria (AU) Pty Ltd ("Lexaria AU") has finalized the terms of its …See details»
Aadi Bioscience Transforms with In-Licensing of Novel ADC …
3 days ago Aadi Bioscience, Inc. (NASDAQ: AADI) today announced it has entered into an exclusive license agreement for development and global commercialization of a three-asset …See details»